Health Condition 1: Q212- Atrioventricular septal defect Health Condition 2: - Health Condition 3: O- Medical and Surgical
Conditions
Interventions
Intervention1: Injection Dexmedetomidine in Caudal Analgesia: Single shot Injection Dexmedetomidine 0.5 microgram/kg in Caudal route.
Duration of intervention - 20 minutes
Control Intervention1: Injec
Sponsors
Research cell JNMC Sawangi Wardha
Eligibility
Inclusion criteria
Inclusion criteria: Patients with Atrial septal defect or ventricular septal defect undergoing intracardiac repair on Cardiopulmonary bypass Weighing 5-15 kg
Exclusion criteria
Exclusion criteria: Patients with multiple cardiac defects, Coagulation abnormalities, Infection at caudal injection site, Any patient receiving sedation Within 24 hours of surgey.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemodynamic response and Postoperative painTimepoint: Hemodynamic Baseline and Intraoperative at specific events - After sternotomy, after bypass ,extubation and in ICU after shifting Pain Score - In ICU for First 8 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| ICU stay, Time to extubationTimepoint: Duration of stay in ICU - 48 hours, 72 hours ; Time of extubation 2 hours,4 hours, 6 hours after surgery | — |
Countries
India
Contacts
Public ContactDr Roshani Manwani
Jawaharlal Nehru Medical College, Sawangi , Wardha
Outcome results
None listed